Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) EVP Andrew Polovin sold 13,135 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $45.98, for a total value of $603,947.30. Following the transaction, the executive vice president now owns 154,171 shares of the company’s stock, valued at $7,088,782.58. This represents a 7.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.
Tempus AI Trading Up 0.0 %
NASDAQ:TEM opened at $48.04 on Friday. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17. The stock’s fifty day moving average price is $56.07 and its two-hundred day moving average price is $51.45. Tempus AI, Inc. has a 52-week low of $22.89 and a 52-week high of $91.45.
Institutional Investors Weigh In On Tempus AI
A number of institutional investors and hedge funds have recently made changes to their positions in the company. ARK Investment Management LLC increased its position in Tempus AI by 132.1% in the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after purchasing an additional 3,141,487 shares during the period. Sumitomo Mitsui Trust Group Inc. grew its position in shares of Tempus AI by 166.0% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares during the period. Nikko Asset Management Americas Inc. raised its stake in shares of Tempus AI by 166.0% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after buying an additional 2,021,394 shares during the last quarter. Franklin Resources Inc. raised its stake in shares of Tempus AI by 240.5% during the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock worth $93,251,000 after buying an additional 1,950,862 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in Tempus AI by 86,947.2% in the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock valued at $55,836,000 after buying an additional 1,651,996 shares during the period. Institutional investors own 24.22% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Analysis on Tempus AI
About Tempus AI
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Recommended Stories
- Five stocks we like better than Tempus AI
- What is the FTSE 100 index?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Buy P&G Now, Before It Sets A New All-Time High
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- What is diluted earnings per share (Diluted EPS)?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.